Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
NCT01660061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2015-04-15
Summary
To Assess the Influence of Antiphospholipid Antibodies on INR Test Results in Patients with the Antiphospholipid Syndrome Anticoagulated with Vitamin-K Antagonists.
Conditions
- Antiphospholipid Syndrome
Sponsors & Collaborators
-
Johann Wolfgang Goethe University Hospital
lead OTHER
Principal Investigators
-
Birgit Linnemann, MD · Goethe University Hospital, Division of Vascular Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis
NCT06650826 ·Status: RECRUITING
-
Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies
NCT02610153 ·Status: COMPLETED
-
Excessive Warfarin Anticoagulation - Causes and Consequences
NCT02761941 ·Status: UNKNOWN
-
Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea
NCT02810509 ·Status: COMPLETED
-
The Prevalence of Sub Optimal Anti Coagulation
NCT03485300 ·Status: UNKNOWN
-
Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
NCT06292117 ·Status: RECRUITING
-
DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study
NCT06884384 ·Status: NOT_YET_RECRUITING
-
Determination of Residual Anticoagulatory Effects of Fondaparinux
NCT01101256 ·Status: UNKNOWN
-
Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
NCT02103101 ·Status: COMPLETED ·Phase: NA
-
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
NCT02286414 ·Status: COMPLETED
-
Anticoagulant Clinics and Vitamin K Antagonists
NCT00966290 ·Status: COMPLETED ·Phase: PHASE4
-
Rivaroxaban for Patients With Antiphospholipid Syndrome
NCT02926170 ·Status: COMPLETED ·Phase: PHASE3
-
Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis
NCT02240953 ·Status: UNKNOWN ·Phase: NA
-
WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)
NCT00769938 ·Status: COMPLETED ·Phase: PHASE4
-
The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Short-term and Long-term Outcomes.
NCT05283174 ·Status: RECRUITING
-
Efficacy of Aspirin in Preventing Venous Thromboembolism
NCT06635317 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Thromboprophylaxis After First-line Total Hip and Knee Replacement
NCT05128214 ·Status: UNKNOWN
-
Factors Associated to the Instability of the INR (International Normalized Ratio ) in the Prevention of Thromboembolism AVK (Anti Vitamin K) in Atrial Fibrillation in the Elderly: Instead of Comorbidities
NCT02841475 ·Status: COMPLETED
-
Assays for and Reversal of New Anticoagulants
NCT01795781 ·Status: COMPLETED
-
Bleeding Events After Triple Antithrombotic Therapy Initiation.
NCT03203980 ·Status: UNKNOWN
-
Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA
NCT02657616 ·Status: COMPLETED
-
The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.
NCT05333666 ·Status: RECRUITING
-
Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
NCT01930916 ·Status: UNKNOWN ·Phase: NA
-
Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
NCT02069132 ·Status: UNKNOWN
-
Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists
NCT02661516 ·Status: COMPLETED